UTI · Insider Trading
Universal Technical Institute, Inc.
Every open-market purchase and sale reported by UTI officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-30 | Robert Thomas Devincenzi | Director | Buy | +1,000 | +$19.68K |
| 2026-09-23 | Robert Thomas Devincenzi | Director | Buy | +1,000 | +$19.83K |
| 2026-08-31 | Robert Thomas Devincenzi | Director | Buy | +1,000 | +$21.80K |
| 2026-08-27 | Robert Thomas Devincenzi | Director | Buy | +1,000 | +$21.77K |
| 2026-08-14 | Robert Thomas Devincenzi | Director | Buy | +1,000 | +$25.95K |
| 2026-08-12 | Robert Thomas Devincenzi | Director | Buy | +8,000 | +$225.68K |
| 2026-06-24 | Kevin Prehn | Concorde Division President | Sell | −4,545 | −$181.80K |
| 2026-06-10 | Christopher S Shackelton | Director | Sell | −15,000,000 | −$621.00M |
| 2026-06-08 | Christine Kline | Senior Vice President and CAO | Sell | −3,500 | −$155.48K |
| 2026-06-08 | William J Lennox Jr | Director | G | −4,600 | — |
| 2026-05-27 | Tracy Kay Lorenz | SVP and UTI Division President | MIXED | +20,170 | −$884.24K |
| 2026-05-13 | Linda J Srere | Director | Sell | −15,000 | −$548.80K |
| 2026-03-18 | George W. Brochick | Director | Sell | −5,000 | −$182.94K |
| 2026-03-09 | Shannon Lei Okinaka | Director | Sell | −10,000 | −$347.41K |
| 2026-03-06 | Kenneth R Trammell | Director | A | +3,565 | — |
| 2026-03-06 | Michael A. Slubowski | Director | A | +3,565 | — |
| 2026-03-06 | Linda J Srere | Director | A | +3,565 | — |
| 2026-03-06 | Robert Thomas Devincenzi | Director | A | +3,565 | — |
| 2026-03-06 | Todd A Hitchcock | EVP/COO | Sell | −16,500 | −$615.95K |
| 2026-03-06 | William J Lennox Jr | Director | A | +3,565 | — |
| 2026-03-06 | Loretta Lydia Sanchez | Director | A | +3,565 | — |
| 2026-03-06 | Shannon Lei Okinaka | Director | A | +3,565 | — |
| 2026-03-06 | George W. Brochick | Director | A | +3,565 | — |
| 2026-03-06 | Sherrell Smith | EVP, Chief Academic Officer | Sell | −50,000 | −$1.69M |
| 2026-03-04 | Sherrell Smith | EVP, Chief Academic Officer | MIXED | −33,745 | −$2.22M |
| 2026-03-02 | Jerome Alan Grant | Chief Executive Officer | Sell | −60,040 | −$2.10M |
| 2026-02-17 | Carolyn Ann Frank | SVP/Chief HR Officer | Sell | −1,750 | −$52.63K |
| 2026-01-21 | Carolyn Ann Frank | SVP/Chief HR Officer | F | −2,162 | −$59.43K |
| 2025-12-19 | Tracy Kay Lorenz | UTI Division President | F | −880 | −$22.93K |
| 2025-12-19 | Sherrell Smith | EVP, Chief Academic Officer | F | −1,321 | −$34.43K |
| 2025-12-19 | Todd A Hitchcock | EVP/COO | F | −2,454 | −$63.95K |
| 2025-12-19 | Kevin Prehn | Concorde Division President | F | −921 | −$24.00K |
| 2025-12-19 | Bruce Schuman | Chief Financial Officer | F | −2,537 | −$66.11K |
| 2025-12-19 | Carolyn Ann Frank | SVP/Chief HR Officer | F | −778 | −$20.27K |
| 2025-12-19 | Christine Kline | Senior Vice President and CAO | F | −2,171 | −$56.58K |
| 2025-12-19 | Jerome Alan Grant | Chief Executive Officer | F | −9,276 | −$241.73K |
| 2025-12-19 | Adrienne Dawn DeTray | SVP and CIO | F | −1,766 | −$46.02K |
| 2025-12-19 | Christopher E. Kevane | EVP and Chief Legal Officer | F | −1,670 | −$43.52K |
| 2025-12-12 | Bruce Schuman | Chief Financial Officer | A | +18,588 | — |
| 2025-12-12 | Tracy Kay Lorenz | UTI Division President | MIXED | +6,045 | −$34.12K |
| 2025-12-12 | Jerome Alan Grant | Chief Executive Officer | MIXED | −39,487 | −$2.74M |
| 2025-12-12 | Carolyn Ann Frank | SVP/Chief HR Officer | A | +9,294 | — |
| 2025-12-12 | Kevin Prehn | Concorde Division President | MIXED | +9,482 | −$108.83K |
| 2025-12-12 | Sherrell Smith | EVP, Chief Academic Officer | MIXED | −18,793 | −$643.90K |
| 2025-12-12 | Christine Kline | Senior Vice President and CAO | MIXED | +2,194 | −$60.22K |
| 2025-12-12 | Christopher E. Kevane | EVP and Chief Legal Officer | MIXED | −3,710 | −$410.53K |
| 2025-12-12 | Adrienne Dawn DeTray | SVP and CIO | A | +9,294 | — |
| 2025-12-12 | Todd A Hitchcock | EVP/COO | MIXED | +3,639 | −$367.00K |
| 2025-12-10 | Todd A Hitchcock | EVP/COO | A | +38,878 | — |
| 2025-12-10 | Christine Kline | Senior Vice President and CAO | A | +5,832 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Coliseum Capital, LLC | Director | 2,887,697 | $53.91M |
| COLISEUM CAPITAL PARTNERS, L.P. | Director | 2,716,267 | $50.71M |
| Christopher S Shackelton | Director | 971,440 | $18.14M |
| Jerome Alan Grant | Chief Executive Officer | 430,215 | $8.03M |
| Lori B Smith | SVP Chief Information Officer | 265,517 | $4.96M |
| Sherrell Smith | EVP, Chief Academic Officer | 170,594 | $3.18M |
| Robert Thomas Devincenzi | Director | 153,330 | $2.86M |
| Kenneth R Trammell | Director | 136,083 | $2.54M |
| Linda J Srere | Director | 127,564 | $2.38M |
| William J Lennox Jr | Director | 118,568 | $2.21M |
| Christopher E. Kevane | EVP and Chief Legal Officer | 107,175 | $2.00M |
| Todd A Hitchcock | EVP/COO | 104,084 | $1.94M |
| Tracy Kay Lorenz | SVP and UTI Division President | 87,518 | $1.63M |
| Christine Kline | Senior Vice President and CAO | 43,006 | $802.92K |
| Bruce Schuman | Chief Financial Officer | 39,577 | $738.90K |
| George W. Brochick | Director | 31,795 | $593.61K |
| Carolyn Ann Frank | SVP/Chief HR Officer | 30,272 | $565.18K |
| Adrienne Dawn DeTray | SVP and CIO | 28,770 | $537.14K |
| Kevin Prehn | Concorde Division President | 27,025 | $504.56K |
| Loretta Lydia Sanchez | Director | 21,590 | $403.09K |
| Michael A. Slubowski | Director | 20,675 | $386.00K |
| Shannon Lei Okinaka | Director | 19,808 | $369.82K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the UTI quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.